Jiangsu Dingtai Pharmaceutical Research
Offering disease model and pharmacodynamics research, drug policy and safety assessment, and clinical and laboratory services, along with a high-quality laboratory animal supply system.
Launch date
Employees
Market cap
-
Enterprise valuation
$688m (Public information from Apr 2023)
Nanjing Jiangsu (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
CNY40.0m | Early VC | ||
N/A | CNY37.8m | Early VC | |
CNY11.0m | Early VC | ||
| CNY1.0b | Late VC | |
* | CNY200m Valuation: CNY5.0b | Series C | |
Total Funding | $177m |